Skip to main content
. 2021 Apr;12(Suppl 1):S242–S258. doi: 10.21037/jgo-20-257

Table 6. Cytological response.

Studies CRC patients Evaluated patients Total PIPAC-OX Response assessment
Progressive Stable Regressive
Ellebæk [2020] (17) 24 15 75 2 8 5
Graversen [2020] (19) 3 3 9 0 2 1

CRC, colorectal cancer; PIPAC-OX, pressurized intraperitoneal aerosol chemotherapy with oxaliplatin.